Nu-Med Plus, Inc. Quarterly Liabilities and Equity in USD from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Nu-Med Plus, Inc. quarterly Liabilities and Equity history and growth rate from Q4 2011 to Q3 2024.
  • Nu-Med Plus, Inc. Liabilities and Equity for the quarter ending September 30, 2024 was $6.84K, a 50.2% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $6.84K -$6.91K -50.2% Sep 30, 2024 10-Q 2024-11-14
Q1 2024 $9.02K -$50.1K -84.7% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $13.5K -$66.1K -83.1% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $13.7K Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $36.5K Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $59.1K +$51.1K +645% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $79.5K +$57.4K +259% Dec 31, 2022 10-K 2024-03-26
Q1 2022 $7.93K -$277K -97.2% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $22.2K -$535K -96% Dec 31, 2021 10-K/A 2023-04-03
Q3 2021 $51.2K -$598K -92.1% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $89.1K -$763K -89.5% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $285K +$238K +504% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $557K +$511K +1117% Dec 31, 2020 10-K/A 2022-04-11
Q3 2020 $650K +$566K +676% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $852K +$799K +1515% Jun 30, 2020 10-Q 2020-08-19
Q1 2020 $47.2K -$107K -69.4% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $45.8K -$377K -89.2% Dec 31, 2019 10-K 2021-03-31
Q3 2019 $83.7K -$469K -84.9% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $52.8K -$284K -84.3% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $155K -$171K -52.5% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $423K +$16.3K +4.01% Dec 31, 2018 10-K 2020-03-30
Q3 2018 $552K +$93K +20.3% Sep 30, 2018 10-Q 2018-11-19
Q2 2018 $337K +$19.5K +6.15% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $325K -$24.7K -7.07% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 $407K +$371K +1045% Dec 31, 2017 10-K 2019-04-01
Q3 2017 $459K +$207K +81.7% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 $317K -$628K -66.4% Jun 30, 2017 10-Q 2017-08-18
Q1 2017 $350K +$223K +175% Mar 31, 2017 10-Q 2017-05-17
Q4 2016 $35.5K -$40.4K -53.2% Dec 31, 2016 10-K 2018-04-03
Q3 2016 $253K +$190K +303% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $945K +$854K +941% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 $127K +$26.5K +26.4% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 $75.9K -$137K -64.4% Dec 31, 2015 10-K 2017-04-19
Q3 2015 $62.7K -$150K -70.6% Sep 30, 2015 10-Q 2015-11-23
Q2 2015 $90.8K -$453K -83.3% Jun 30, 2015 10-Q 2015-08-12
Q1 2015 $101K -$401K -79.9% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 $213K +$117K +122% Dec 31, 2014 10-K 2016-04-13
Q3 2014 $213K +$146K +220% Sep 30, 2014 10-Q 2015-11-23
Q2 2014 $544K +$474K +679% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $502K +$431K +615% Mar 31, 2014 10-Q 2014-05-13
Q4 2013 $96K -$14.4K -13% Dec 31, 2013 10-K 2015-03-23
Q3 2013 $66.6K Sep 30, 2013 10-Q 2013-11-14
Q2 2013 $69.8K Jun 30, 2013 10-Q 2013-08-13
Q1 2013 $70.1K Mar 31, 2013 10-Q 2013-05-14
Q4 2012 $110K +$109K +7752% Dec 31, 2012 10-K 2014-02-21
Q4 2011 $1.41K Dec 31, 2011 10-K 2013-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.